220 related articles for article (PubMed ID: 20180072)
41. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
42. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
Surgery; 2015 Dec; 158(6):1500-11. PubMed ID: 26120069
[TBL] [Abstract][Full Text] [Related]
43. A Tale of Two Cancers: Traveling to Treat Pancreatic and Thyroid Cancer.
White MG; Applewhite MK; Kaplan EL; Angelos P; Huo D; Grogan RH
J Am Coll Surg; 2017 Jul; 225(1):125-136.e6. PubMed ID: 28473189
[TBL] [Abstract][Full Text] [Related]
44. Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.
Griniatsos J; Tsigris C; Kanakis M; Kaltsas G; Michail O; Dimitriou N; Argyrakopoulou G; Delladetsima I; Kyriakou V; Syriou V; Alexandraki K; Pikoulis E; Giannopoulos A; Kouraklis G; Diamanti-Kandaraki E; Felekouras E
Anticancer Res; 2009 Dec; 29(12):5163-9. PubMed ID: 20044632
[TBL] [Abstract][Full Text] [Related]
45. Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up.
Onuma AE; Beal EW; Nabhan F; Hughes T; Farrar WB; Phay J; Ringel MD; Kloos RT; Shirley LA
Ann Surg Oncol; 2019 Jun; 26(6):1737-1743. PubMed ID: 30820785
[TBL] [Abstract][Full Text] [Related]
46. American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma.
Carling T; Carty SE; Ciarleglio MM; Cooper DS; Doherty GM; Kim LT; Kloos RT; Mazzaferri EL; Peduzzi PN; Roman SA; Sippel RS; Sosa JA; Stack BC; Steward DL; Tufano RP; Tuttle RM; Udelsman R;
Thyroid; 2012 Mar; 22(3):237-44. PubMed ID: 22313454
[TBL] [Abstract][Full Text] [Related]
47. Low-risk papillary thyroid carcinoma patients who underwent near-total thyroidectomy without prophylactic central compartment lymph node dissection and were ablated with low-dose 50mCi RAI had excellent 10-year prognosis.
Michalaki M; Bountouris P; Roupas ND; Theodoropoulou A; Agalianou N; Alexandrides T; Markou K
Hormones (Athens); 2016 Oct; 15(4):511-517. PubMed ID: 28222412
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
[TBL] [Abstract][Full Text] [Related]
49. Level VI lymph node dissection for papillary thyroid cancer.
White ML; Doherty GM
Minerva Chir; 2007 Oct; 62(5):383-93. PubMed ID: 17947949
[TBL] [Abstract][Full Text] [Related]
50. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
Dong S; Xia Q; Wu YJ
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
[TBL] [Abstract][Full Text] [Related]
51. Total thyroidectomy is the recommended treatment for all Papillary Thyroid Carcinoma (PTC).
Santini J; Haddad A
Acta Otorhinolaryngol Belg; 1999; 53(3):161-4. PubMed ID: 10635384
[TBL] [Abstract][Full Text] [Related]
52. Ultrasonographic differentiation of cervical lymph nodes in patients with papillary thyroid carcinoma after thyroidectomy and radioiodine ablation: a prospective study.
Rosário PW; Tavares WC; Borges MA; Santos JB; Calsolari MR
Endocr Pract; 2014 Apr; 20(4):293-8. PubMed ID: 24246348
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid.
Ito Y; Miyauchi A
Endocr J; 2009; 56(2):177-92. PubMed ID: 18703852
[TBL] [Abstract][Full Text] [Related]
54. Solitary hemorrhagic cerebellar metastasis from occult papillary thyroid microcarcinoma.
Lecumberri B; Alvarez-Escolá C; Martín-Vaquero P; Nistal M; Martín V; Riesco-Eizaguirre G; Sosa G; Pallardo LF
Thyroid; 2010 May; 20(5):563-7. PubMed ID: 20450434
[TBL] [Abstract][Full Text] [Related]
55. Papillary thyroid carcinoma: debate at rest.
Sonkar AA; Rajamanickam S; Singh D
Indian J Cancer; 2010; 47(2):206-16. PubMed ID: 20448388
[TBL] [Abstract][Full Text] [Related]
56. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
[TBL] [Abstract][Full Text] [Related]
57. Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?
Soares P; Celestino R; Gaspar da Rocha A; Sobrinho-Simões M
Int J Surg Pathol; 2014 Apr; 22(2):113-9. PubMed ID: 24401191
[TBL] [Abstract][Full Text] [Related]
58. Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases.
Sabra MM; Grewal RK; Ghossein RA; Tuttle RM
Thyroid; 2014 Jul; 24(7):1088-95. PubMed ID: 24559250
[TBL] [Abstract][Full Text] [Related]
59. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
Endocr Relat Cancer; 2016 May; 23(5):367-76. PubMed ID: 26917553
[TBL] [Abstract][Full Text] [Related]
60. In search of an unstimulated thyroglobulin baseline value in low-risk papillary thyroid carcinoma patients not receiving radioactive iodine ablation.
Angell TE; Spencer CA; Rubino BD; Nicoloff JT; LoPresti JS
Thyroid; 2014 Jul; 24(7):1127-33. PubMed ID: 24697314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
